Science Explorer Back to mapMap
Researcher · Sarah Cannon · United States

Jesús G. Berdeja

Jesús G. Berdeja publishes mostly in Hematology, Molecular Biology and Oncology, on topics such as Multiple Myeloma Research and Treatments, CAR-T cell therapy research and Protein Degradation and Inhibitors.

ORCID 0000-0003-4362-0376 OpenAlex
World rank
#323,913
of 7,710,434 ranked researchers
Rank in United States
#116,942
of 1,627,098
Works
537
Citations
20k
Citations per work
36.6
h-index
61
i10-index 200Top 2% in Hematology

What does Jesús G. Berdeja research?

Jesús G. Berdeja's work is mostly in Medicine (61%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (6%).

Life Sciences27%Health Sciences61%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine32660.7%
    1. Biochemistry, Genetics and Molecular Biology11421.3%
    2. Immunology and Microbiology315.7%
  1. Everything else6612.3%
  1. 1Hematology31% of their works
  2. 2Molecular Biology21% of their works
  3. 3Oncology20% of their works
  4. 4Genetics6% of their works
  5. 5Immunology6% of their works
  6. 6Radiology, Nuclear Medicine and Imaging4% of their works

Research topics

Which keywords describe Jesús G. Berdeja's research?

The keywords of their largest research topics: Diagnosis Criteria, International Myeloma Working Group, CAR T Cells, Chimeric Antigen Receptor, BET Bromodomains, PROTACs, Prognostic Factors and Monoclonal Antibodies.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Diagnosis Criteria3131 topic
  2. International Myeloma Working Group3131 topic
  3. CAR T Cells1531 topic
  4. Chimeric Antigen Receptor1531 topic
  5. BET Bromodomains1341 topic
  6. PROTACs1341 topic
  7. Prognostic Factors1042 topics
  8. Monoclonal Antibodies802 topics
  9. Chronic Lymphocytic Leukemia641 topic
  10. Genomic Aberrations641 topic
  11. Biosimilars411 topic
  12. Immunogenicity411 topic
  13. AML401 topic
  14. Acute Myeloid Leukemia401 topic
  15. Fc Receptors391 topic
  16. Therapeutic Antibodies391 topic
  17. Chemotherapy-Induced Peripheral Neuropathy361 topic
  18. Taxanes361 topic

Where does Jesús G. Berdeja work?

Jesús G. Berdeja's main affiliation in the publication record is Sarah Cannon, United States.

How many publications and citations does Jesús G. Berdeja have?

OpenAlex counts 537 works and 19,638 citations for Jesús G. Berdeja, an h-index of 61, ranking #323,913 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jesús G. Berdeja. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.